Core Viewpoint - A class action securities lawsuit has been filed against WPP plc, alleging securities fraud that negatively impacted investors between February 27, 2025, and July 8, 2025 [1][2] Group 1: Lawsuit Details - The lawsuit claims that WPP provided overly positive statements while concealing material adverse facts about its media arm's ability to handle macroeconomic challenges and competition, leading to a loss of market share [2] - On July 9, 2025, WPP reported a deterioration in performance for Q2 2025, attributing this to macroeconomic uncertainty and weaker new business, which was compounded by ongoing restructuring efforts [2] - Following the trading update, WPP's stock price fell from $35.82 per share on July 8, 2025, to $29.34 per share on July 9, 2025, marking a decline of approximately 18.1% in one day [2] Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until December 8, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this role [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky has a history of securing significant settlements for shareholders and is recognized as one of the top securities litigation firms in the United States, with over 70 employees dedicated to client service [4]

Core Viewpoint - A class action securities lawsuit has been filed against Fluor Corporation, alleging securities fraud that negatively impacted investors between February 18, 2025, and July 31, 2025 [1][2]. Group 1: Allegations and Impact - The lawsuit claims that Fluor Corporation concealed rising costs associated with infrastructure projects due to subcontractor design errors, price increases, and scheduling delays [2]. - It is alleged that these issues, along with reduced capital spending from customers and economic uncertainty, significantly harmed the Company's business and financial results [2]. - The financial guidance provided by Fluor for FY 2025 is claimed to be unreliable, with overstated risk mitigation strategies and understated impacts of economic uncertainty [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until November 14, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this role [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, indicating no financial obligation to participate [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions for shareholders over the past 20 years [4]. - The firm is recognized as one of the top securities litigation firms in the United States, ranking in ISS Securities Class Action Services' Top 50 Report for seven consecutive years [4].

Core Viewpoint - V.F. Corporation is facing a class action securities lawsuit due to alleged securities fraud that negatively impacted investors between October 30, 2023, and May 20, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that V.F. Corporation made materially false and misleading statements regarding its turnaround plans, particularly concerning the Vans brand, which required significant reset actions to return to growth [2]. - Following the release of V.F. Corporation's fiscal 2025 results on May 21, 2025, it was revealed that Vans experienced a decline in growth, with losses worsening from 8% to 20% in the fourth quarter [2]. - The company attributed its disappointing results to deliberate revenue reductions aimed at eliminating unprofitable segments, indicating that even without these actions, Vans would have shown a high single-digit revenue decline [2]. Group 2: Stock Price Impact - On May 21, 2025, V.F. Corporation's stock price dropped from $14.43 to $12.15 per share, marking a decline of approximately 15.8% in one day following the negative earnings report [2]. Group 3: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until November 12, 2025, to request appointment as lead plaintiff in the lawsuit, although participation does not require this role [3]. - Class members may be entitled to compensation without incurring any out-of-pocket costs or fees [3]. Group 4: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions for shareholders over the past 20 years and consistently ranking among the top securities litigation firms in the U.S. [4].

Core Viewpoint - UniQure N.V. is under investigation for potential securities law violations following a significant drop in its stock price after the FDA deemed its clinical data for an experimental gene therapy insufficient [2][4]. Group 1: Company Overview - UniQure's shares fell by as much as 66% after the FDA's announcement regarding its gene therapy for Huntington's disease [2]. - The FDA's decision represents a considerable shift from previous communications between the regulator and UniQure [2]. Group 2: Investigation Details - Block & Leviton is investigating UniQure's disclosures to determine if there were any violations of securities laws [4]. - The firm is reaching out to investors who have lost money in their UniQure investments to discuss potential recovery options [1][3]. Group 3: Investor Actions - Investors who purchased UniQure common stock and experienced a decline in share value may be eligible to participate in the investigation [3]. - Block & Leviton encourages affected investors to contact them for more information on recovery [5][7].

Core Viewpoint - The James Hardie Industries plc is facing a class action lawsuit for allegedly misleading investors about the strength of its North American Fiber Cement segment, which experienced significant inventory destocking and a subsequent decline in sales [3][4]. Group 1: Class Action Lawsuit Details - The class action lawsuit is titled "Laborers' District Council and Contractors' Pension Fund of Ohio v. James Hardie Industries plc" and is filed in the Northern District of Illinois [1]. - The lawsuit alleges that James Hardie and its executives violated the Securities Exchange Act of 1934 by making false statements regarding the company's performance during a challenging market environment [1][3]. - Investors who purchased James Hardie common stock between May 20, 2025, and August 18, 2025, can seek appointment as lead plaintiff until December 23, 2025 [1][5]. Group 2: Allegations Against James Hardie - The lawsuit claims that James Hardie misled investors by assuring them that the North American Fiber Cement segment remained strong, despite evidence of inventory destocking starting in April and May 2025 [3]. - On August 19, 2025, James Hardie disclosed a 12% decline in sales for the North American Fiber Cement segment, which led to a stock price drop of over 34% [4]. Group 3: Legal Representation - Robbins Geller Rudman & Dowd LLP is representing investors in this class action lawsuit and is recognized as a leading law firm in securities fraud and shareholder litigation [6]. - The firm has a strong track record, having recovered over $2.5 billion for investors in 2024 alone, and is known for securing significant monetary relief in securities class action cases [6].

Core Viewpoint - A class action lawsuit has been filed against Fluor Corporation (FLR) by Berger Montague on behalf of investors who acquired shares between February 18, 2025, and July 31, 2025, due to alleged misrepresentation of the company's financial condition and undisclosed issues with major infrastructure projects [1][3]. Company Overview - Fluor Corporation, headquartered in Irving, Texas, provides engineering, procurement, construction, and project management services globally, with its Urban Solutions segment being the largest revenue contributor [2]. Allegations and Investigation - The investigation focuses on claims that FLR misrepresented its financial health and concealed escalating issues related to significant infrastructure projects, including rising costs and delays in the Gordie Howe, I-635/LBJ, and I-35 projects [3]. Financial Performance - On August 1, 2025, FLR reported disappointing Q2 2025 results, with earnings per share (EPS) of $0.43 and revenue of $3.98 billion, missing consensus estimates by $0.13 and $570 million, respectively. The company reduced its full-year forecast, attributing the shortfall to project execution failures and a slowdown in new contract awards. Following this announcement, FLR's stock price fell over 27%, closing at $41.42 on the same day [4]. Market Reaction - In response to the negative news, several brokerages downgraded FLR's stock, citing significant concerns regarding the company's internal controls and transparency [5].

Core Viewpoint - A lawsuit has been filed against Molina Healthcare, Inc. and certain senior executives for potential violations of federal securities laws, with claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [1][2]. Group 1: Lawsuit Details - Investors have until December 2, 2025, to request to lead the case, which is pending in the U.S. District Court for the Central District of California [2]. - The lawsuit is titled Hindlemann v. Molina Healthcare, Inc., et al., No. 25-cv-9461 [2]. Group 2: Company Background - Molina Healthcare is a health insurance company providing managed healthcare services to low-income individuals under Medicaid and Medicare programs [3]. - The company previously claimed a "solid" earnings growth profile heading into 2025 and stated it was monitoring utilization patterns to mitigate healthcare cost inflation [3]. Group 3: Financial Performance and Stock Impact - On July 7, 2025, Molina reported Q2 2025 adjusted earnings of approximately $5.50 per share, which was below prior expectations due to medical cost pressures across all business lines [4]. - The company cut its guidance for expected adjusted earnings per share by 10.2% to a range of $21.50 to $22.50 per share [4]. - Following further revelations on July 23, 2025, Molina adjusted its full-year 2025 earnings expectation to no less than $19.00 per diluted share, citing a challenging medical cost trend environment [4]. - The stock price fell by $32.03 per share, or 16.8%, from $190.25 on July 23, 2025, to $158.22 on July 24, 2025, in response to these announcements [4].

Core Viewpoint - CarMax, Inc. is under investigation for potential violations of federal securities laws, following disappointing financial results and claims regarding its assessment of car loan risks [1][4]. Group 1: Investigation Details - The investigation is initiated by Bleichmar Fonti & Auld LLP, a leading securities law firm, focusing on CarMax's practices related to federal securities laws [1]. - CarMax had previously claimed strong demand for its vehicles and proper risk assessment for car loans, which is now being scrutinized [2]. Group 2: Financial Performance - CarMax reported a 5.4% decline in retail used unit sales, a 6.3% decline in comparable store used unit sales, and a 2.2% decline in wholesale units for Q2 of fiscal year 2026 [4]. - The company's net earnings for Q2 were approximately $95.4 million, down from $132.8 million in the previous year, attributed to a "pull forward" in demand due to U.S. tariffs [4]. - A significant 11.2% decrease in income from the financing segment year-over-year was reported, with a loan loss provision of $142.2 million for the quarter [4]. Group 3: Stock Market Reaction - Following the announcement of disappointing financial results, CarMax's stock price fell by $11.45 per share, approximately 20%, from $57.05 on September 24, 2025, to $45.60 on September 25, 2025 [5].

Core Viewpoint - A class action lawsuit has been filed against James Hardie Industries plc and certain senior executives for securities fraud following a significant stock drop due to potential violations of federal securities laws [1][3]. Company Overview - James Hardie is a producer and marketer of high-performance fiber cement building solutions, primarily used in external siding for the residential building industry in the United States and Canada [4]. Allegations and Misrepresentation - During the relevant period, James Hardie claimed that its North American fiber cement segment showed "inherent strength" and "underlying momentum," while in reality, sales were driven by inventory loading by channel partners, indicating fraudulent channel stuffing rather than sustainable customer demand [5]. Stock Performance and Impact - On August 19, 2025, James Hardie reported a 12% decline in North American fiber cement sales, attributed to destocking efforts by customers. Following this announcement, the stock price plummeted by $9.79 per share, or over 34%, from $28.43 to $18.64 [6].

Core Viewpoint - Stride, Inc. is under investigation for potential violations of federal securities laws, following a significant drop in its stock price due to poor customer experiences stemming from platform changes [1][4]. Company Overview - Stride, Inc. is an education technology company that provides an online platform for students across the U.S. [2]. - The company previously reported "record demand" for its products and services, indicating strong customer interest [2]. Recent Developments - Stride's stock price fell by more than 54%, dropping from $153.53 to $70.05 per share after the company disclosed that its growth rate did not meet expectations due to poorly executed upgrades [4][5]. - The upgrades led to a "poor customer experience," resulting in higher withdrawal rates and lower conversion rates, with an estimated loss of 10,000-15,000 enrollments [4]. Legal Implications - Bleichmar Fonti & Auld LLP is investigating Stride for potential securities fraud, encouraging affected investors to seek additional information [1][6].